Hydrocortisone vs placebo
- Early pharmacological interventions for prevention of post‐traumatic stress disorder (PTSD) in individuals… 2024 · Cochrane Headline outcomes onlyno estimate extracted1 study · 43 participantsVery low
It is very uncertain whether escitalopram changes PTSD rate at 3 months compared with placebo (very low certainty).
The review found no eligible studies for this question.
The review found no eligible studies for this question.
Hydrocortisone showed no clear difference in dropouts due to adverse events at 3 months compared with placebo (low certainty).
It is very uncertain whether hydrocortisone changes PTSD rate at 3 months compared with placebo (very low certainty).
The review found no eligible studies for this question.
The review found no eligible studies for this question.
Local excision showed no clear difference in disease‐free survival (D‐FS)Â compared with radical resection (low certainty).
It is very uncertain whether local excision changes cancer‐related survival (C‐RS)Â compared with radical resection (very low certainty).
Local excision showed no clear difference in major postoperative complications compared with radical resection (low certainty).
Local excision probably leads to lower minor postoperative complications compared with radical resection (moderate certainty).
Nasal intermittent positive pressure ventilation (NIPPV) probably leads to lower respiratory failure compared with nasal continuous positive airway pressure (NCPAP) (by population) (moderate certainty).
Nasal intermittent positive pressure ventilation (NIPPV) probably leads to lower need for endotracheal tube ventilation compared with nasal continuous positive airway pressure (NCPAP) (by population) (moderate certainty).
Nasal intermittent positive pressure ventilation (NIPPV) showed no clear difference in mortality during study period compared with nasal continuous positive airway pressure (NCPAP) (by population) (low certainty).